Mechanisms of fatal opioid overdose - PubMed (original) (raw)
Affiliations
- PMID: 10707430
Review
Mechanisms of fatal opioid overdose
J M White et al. Addiction. 1999 Jul.
Abstract
There has been increasing recognition of the problem of fatal opioid overdose. This review examines the pharmacological basis of respiratory depression following opioid administration. Respiration is controlled principally through medullary respiratory centres with peripheral input from chemoreceptors and other sources. Opioids produce inhibition at the chemoreceptors via mu opioid receptors and in the medulla via mu and delta receptors. While there are a number of neurotransmitters mediating the control of respiration, glutamate and GABA are the major excitatory and inhibitory neurotransmitters, respectively. This explains the potential for interaction of opioids with benzodiazepines and alcohol: both benzodiazepines and alcohol facilitate the inhibitory effect of GABA at the GABAA receptor, while alcohol also decreases the excitatory effect of glutamate at NMDA receptors. Heroin and methadone are the major opioids implicated in fatal overdose. Heroin has three metabolites with opioid activity. Variation in the formation of these metabolites due to genetic factors and the use of other drugs could explain differential sensitivity to overdose. Metabolites of methadone contribute little to its action. However, variation in rate of metabolism due to genetic factors and other drugs used can modify methadone concentration and hence overdose risk. The degree of tolerance also determines risk. Tolerance to respiratory depression is less than complete, and may be slower than tolerance to euphoric and other effects. One consequence of this may be a relatively high risk of overdose among experienced opioid users. While agonist administration modifies receptor function, changes (usually in the opposite direction) also result from use of antagonists. The potential for supersensitivity to opioids following a period of administration of antagonists such as naltrexone warrants further investigation. While our understanding of the pharmacological basis of opioid-related respiratory depression has advanced, better understanding of the role of heroin metabolites, the metabolism of methadone, drug interactions and tolerance would all be of considerable value in knowing how best to respond to this problem.
Comment in
- Heroin overdose is often the truer description.
Tagliaro F, De Battisti Z. Tagliaro F, et al. Addiction. 1999 Jul;94(7):973-4. doi: 10.1080/09652149933108. Addiction. 1999. PMID: 10707431 No abstract available.
Similar articles
- [Mechanisms of opioid-induced overdose: experimental approach to clinical concerns].
Baud FJ. Baud FJ. Ann Pharm Fr. 2009 Sep;67(5):353-9. doi: 10.1016/j.pharma.2009.06.005. Epub 2009 Aug 3. Ann Pharm Fr. 2009. PMID: 19695371 Review. French. - Reversal of morphine, methadone and heroin induced effects in mice by naloxone methiodide.
Lewanowitsch T, Miller JH, Irvine RJ. Lewanowitsch T, et al. Life Sci. 2006 Jan 11;78(7):682-8. doi: 10.1016/j.lfs.2005.05.062. Epub 2005 Aug 15. Life Sci. 2006. PMID: 16102783 - Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P. Pergolizzi J, et al. Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23. Pain Pract. 2008. PMID: 18503626 - [Heroin, part III: the pharmacology of heroin].
Hosztafi S. Hosztafi S. Acta Pharm Hung. 2003;73(3):197-205. Acta Pharm Hung. 2003. PMID: 15112443 Hungarian. - Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.
Ngo HT, Tait RJ, Hulse GK. Ngo HT, et al. Arch Gen Psychiatry. 2008 Apr;65(4):457-65. doi: 10.1001/archpsyc.65.4.457. Arch Gen Psychiatry. 2008. PMID: 18391134
Cited by
- Separate and combined psychopharmacological effects of alprazolam and oxycodone in healthy volunteers.
Zacny JP, Paice JA, Coalson DW. Zacny JP, et al. Drug Alcohol Depend. 2012 Aug 1;124(3):274-82. doi: 10.1016/j.drugalcdep.2012.01.023. Epub 2012 Feb 25. Drug Alcohol Depend. 2012. PMID: 22365897 Free PMC article. Clinical Trial. - Buprenorphine Pharmacology Review: Update on Transmucosal and Long-acting Formulations.
Coe MA, Lofwall MR, Walsh SL. Coe MA, et al. J Addict Med. 2019 Mar/Apr;13(2):93-103. doi: 10.1097/ADM.0000000000000457. J Addict Med. 2019. PMID: 30531584 Free PMC article. Review. - Methadone: applied pharmacology and use as adjunctive treatment in chronic pain.
Brown R, Kraus C, Fleming M, Reddy S. Brown R, et al. Postgrad Med J. 2004 Nov;80(949):654-9. doi: 10.1136/pgmj.2004.022988. Postgrad Med J. 2004. PMID: 15537850 Free PMC article. Review. - Effects of midazolam on cardiovascular responses and isoflurane requirement during elective ovariohysterectomy in dogs.
Kropf J, Hughes JML. Kropf J, et al. Ir Vet J. 2018 Dec 17;71:26. doi: 10.1186/s13620-018-0136-y. eCollection 2018. Ir Vet J. 2018. PMID: 30568789 Free PMC article. - The association between social stressors and drug use/hazardous drinking among former prison inmates.
Calcaterra SL, Beaty B, Mueller SR, Min SJ, Binswanger IA. Calcaterra SL, et al. J Subst Abuse Treat. 2014 Jul;47(1):41-9. doi: 10.1016/j.jsat.2014.02.002. Epub 2014 Mar 1. J Subst Abuse Treat. 2014. PMID: 24642070 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials